Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by Valuehunter72on Jun 25, 2020 6:32pm

74 Views

Post# 31192763

Magpies

About to get a whole lotta cheap shares.

Think about it.

They can't even close a PP below market value on time. Your bags just got heavier BeWhere.

cheep cheep cheep said the Magpie. I mean cheap cheap cheap.

Lets focus on DD.....oh wait...the company has gone into silent mode....tough to find anything.

Luckily Wave 2 has arrived....Annnnnd still silent.

16 vaccines advanced out of preclinical now.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 7, 2024